Oncolytics Biotech buy Cantor Fitzgerald
Start price
06.03.23
/
50%
€1.61
Target price
06.03.24
-
Performance (%)
-
End price
07.03.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Oncolytics Biotech | - | - | - |
| iShares Core DAX® | 1.051% | -1.833% | 12.822% |
| iShares Nasdaq 100 | -0.547% | -3.738% | 40.625% |
| iShares Nikkei 225® | -1.778% | -8.115% | 16.092% |
| iShares S&P 500 | 0.002% | -2.226% | 28.387% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Oncolytics Biotech diskutieren
Oncolytics Biotech Inc. (NASDAQ: ONCY) is now covered by analysts at Cantor Fitzgerald. They set an "overweight" rating on the stock.
Ratings data for ONCY provided by MarketBeat
In the thread Trading Oncolytics Biotech
Die von Cantor_Fitzgerald gewählte maximale Laufzeit wurde überschritten